Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-13 07:55 am Purchase | 13G | BRAINSTORM CELL THERAPEUTICS I BCLI | Ruck Matthew J | 275,838 5.180% | 275,838 (New Position) | View |
| 2023-11-29 3:14 pm Purchase | 13G | BIT BRO LTD 2 BETSF | Ruck Matthew J | 15,730,996 7.000% | 1,050,000 (+7.15%) | View |
| 2023-11-22 08:58 am Purchase | 13G | BIT BRO LTD 2 BETSF | Ruck Matthew J | 14,680,996 6.500% | 2,975,000 (+25.41%) | View |
| 2023-11-20 08:56 am Purchase | 13G | BIT BRO LTD 2 BETSF | Ruck Matthew J | 11,705,996 5.200% | 10,005,996 (+588.59%) | View |
| 2023-06-22 2:49 pm Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Ruck Matthew J | 1,700,000 6.180% | 96,994 (+6.05%) | View |
| 2023-06-14 2:42 pm Unchanged | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Ruck Matthew J | 1,603,006 5.830% | 0 (Unchanged) | View |
| 2023-06-14 10:41 am Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Ruck Matthew J | 1,603,006 5.830% | 55,580 (+3.59%) | View |
| 2023-06-09 10:42 am Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Ruck Matthew J | 1,547,426 5.600% | 1,547,426 (New Position) | View |